Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Redx Pharma Plc LSE:REDX London Ordinary Share GB00BSNB6S51 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 59.00 29,852 08:00:14
Bid Price Offer Price High Price Low Price Open Price
55.00 63.00 62.25 58.75 59.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 3.13 -6.34 -3.40 162
Last Trade Time Trade Type Trade Size Trade Price Currency
16:07:54 O 23,979 55.35 GBX

Redx Pharma (REDX) Latest News

More Redx Pharma News
Redx Pharma Investors    Redx Pharma Takeover Rumours

Redx Pharma (REDX) Discussions and Chat

Redx Pharma Forums and Chat

Date Time Title Posts
23/12/202013:44Redx Pharma PLC481
02/7/202007:39REDX Pharma Discussion Thread Moderated157

Add a New Thread

Redx Pharma (REDX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-01-22 17:05:0155.3523,97913,272.38O
2021-01-22 16:07:5562.801710.68O
2021-01-22 15:47:3355.3563.32O
2021-01-22 15:43:3555.3573.87O
2021-01-22 15:43:2755.3563.32O
View all Redx Pharma trades in real-time

Redx Pharma (REDX) Top Chat Posts

DateSubject
22/1/2021
08:20
Redx Pharma Daily Update: Redx Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker REDX. The last closing price for Redx Pharma was 59p.
Redx Pharma Plc has a 4 week average price of 55.50p and a 12 week average price of 49.20p.
The 1 year high share price is 92.50p while the 1 year low share price is currently 5p.
There are currently 273,887,213 shares in issue and the average daily traded volume is 27,759 shares. The market capitalisation of Redx Pharma Plc is £161,593,455.67.
28/8/2020
14:10
wapper: Possibly the Best Buy on the market is right here at REDX. Share price should be a multiple of this level. I'm not selling mine at these levels.
20/8/2020
17:48
supercity: This is why it spiked a few weeks ago and only fell back on the redmile concernsRedx signs out licensing agreement with AstraZeneca-- AstraZeneca granted exclusive global licence for the development and commercialisation of RXC006, a porcupine inhibitor, for fibrotic diseases-- Redx will receive up to $17 million in early payments between deal signature and the successful commencement of first clinical trial-- Redx will receive up to a further $360 million in development and commercial milestones, plus tiered royalties
20/8/2020
13:33
fission453: fferor: RM Special Holdings 3, LLC Offer terms: GBP0.155 in cash per share Pay date: upon receipt Please be aware that we incorrectly advised that RM Special Holdings 3, LLC were compulsorily acquiring the remaining shares in Redx Pharma and that we will accept the offer for all remaining holders around the 25th August 2020. Unfortunately this information was incorrect and the shares are not being compulsorily acquired. Therefore, all elections to accept the offer made following our compulsory acquisition notice do not stand. Please accept our apologies for any inconvenience caused. RM Special Holdings 3, LLC is offering to purchase all of the issued and outstanding shares in Redx Pharma plc. Your options are: OPTION 1: Do nothing (Default). You will keep your current holding if you do nothing. OPTION 2: Accept the offer and receive GBP0.155 cash in exchange for each Redx Pharma plc share held.
19/8/2020
17:46
kennylogsin: Supercity - thanks for pointing out the 92% holding. I was running from the email alert issued by HL yesterday which opened with: Our Reference: 02648800 Dear Mr XXXXXXX RedX Pharma plc - Your holding of xx,xxx Shares Extended Cash Offer - Important information that requires your attention What is happening? Redmile Group recently bought approximately 39.5% of the RedX Pharma plc shares in issue at a price of 15.5p per share. Under UK company law the company has to offer to buy all remaining RedX shares at the same price. As a holder of RedX Pharma plc Shares in your Hargreaves Lansdown Stocks & Shares ISA you need to decide whether you wish to accept the Offer or not. At the time of writing RedX Pharma plc Shares are trading at 45p so you may get less cash by accepting this offer than you would trading your Shares in the market. The other part I stated was at the bottom of the communication: What happens if I do not accept the Offer? If Redmile is able to obtain acceptances for 90% of the Company's Shares then they can force all remaining Shareholders to sell their Shares at the offer price. Redmile has indicated that if it receives acceptances in excess of 90% it does not currently intend to exercise its rights to compulsorily acquire the remaining RedX Pharma plc Shares. If the Company receives acceptances in excess of 90% and does move to compulsorily acquire the remaining Shares, we will put forward your holding for acceptance of the Offer, as long as it remains open, in order to ensure that you receive proceeds in respect of your holding as soon as possible. If not you will receive the proceeds once the Compulsory Acquisition has been completed. Redmile has stated that it intends to maintain RedX Pharma plc’s listing on AIM. However, if AIM is no longer considered a suitable market for RedX shares, Redmile may seek to move to a different market or trading facility. Super - as I got this yesterday how is it 8 week old information? Was something issued somewhere else? Any advice welcome...
19/8/2020
16:20
supercity: Redmile have said they don't intend to compulsory purchase the remaining shares but this was eight weeks ago when the share price was around the 15-20p level.They already own 92% of the company so will obviously vote yes to what ever they decide to do.Unless they issue a statement to say they don't intend to buy the remaining shares (which they will only have to pay 15.5p for) and want to leave the listing as it is you are always going to be nervous holding shares.
11/8/2020
19:14
global nomad: received reminder notice from iweb today...apologies to hahmedk for misconstruing his previous posts...para 3 and 4 are key but still a little vague...questions is still about selling on market asap or gambling on the listing remaining active after aug 24th - those paragraphs seem to suggest it might. ---- originally published by iweb on 19th June Further to our previous correspondence, Redmile has received valid acceptances of the Offer in respect of approximately 91.76 percent of the existing issued share capital of REDX as of 30th April 2020. Consequently, as Redmile has received acceptances under the Offer in respect of, and/or otherwise acquired 90 percent or more of the REDX shares in issue, Redmile is required to notify shareholders of their rights pursuant to the provisions of sections 983-985 of the Companies Act 2006 (The Act) to require Redmile to acquire the remaining REDX shares on the same terms as the Offer. Please note, it is not Redmile's intention to exercise their right under Chapter 3 of Part 28 of the Act to acquire compulsorily the remaining Ordinary shares to which the Offer relates and in respect of which the Offer has not been accepted. Redmile intends to maintain the admission of REDX Shares to trading on AIM immediately after the Offer. Should REDX be deemed to be unsuitable for admission to trading on AIM following Completion for any reason Redmile intends to investigate whether a listing on an alternative exchange or establishing an alternative trading facility would provide material benefits to shareholders through the continued ability to trade their shares. Before making any decision please take into consideration all relevant factors of the event including the current share price and any possible tax implications. If you require any further information in making your decision please contact an appropriate professional advisor. Please be aware that should you choose to accept the Offer, we do not yet know when the cash proceeds will be paid. However, we will notify you once your entitlement has been credited to your account. Should you choose not to accept the Offer at this time, we will contact you again if the Offer is extended, the terms of the Offer change, or if we are notified that the Offer is closing. Please note that acceptance to this Offer will only be applied to the number of shares you hold at the time we process your instruction. Please note that should you elect to accept the Offer, your shares will be removed from your account after our Advice Date and will not be available for you to sell. Should you wish to find more information about the Offer, please visit www.redxpharma.com/ What Happens If I Don't Elect ? If you do not wish to accept the Offer at this stage then you should take no action.
05/8/2020
06:33
bowssbyjuhelm: Iain Ross, Chairman of the Board of Redx commented : "We are delighted to welcome such an experienced director onto the Redx Board. I am looking forward to working with Tom and to ensuring that we grow Redx into a substantive biotech company."What I like to hear first thing in the morning! ;)
01/7/2020
15:54
noirua: 92.03% of shares held by Red Mile Group, San Francisco https://uk.advfn.com/stock-market/london/redx-pharma-REDX/share-news/Redx-Pharma-plc-Holdings-in-Company/82755282 A big crash by the shares after the runup - 1 July 2020 - RNS - Share purchases by Iain Ross and Peter Pressland - managerially associated. https://uk.advfn.com/stock-market/london/redx-pharma-REDX/share-news/Redx-Pharma-plc-Director-PDMR-Shareholding/82769194
14/3/2020
09:45
thefartingcommie: Redx Pharma set to be bought by US investment group UK biotech firm Redx Pharma (AIM: REDX) has a new majority shareholder, investment group Redmile, after the USA-based company bought up nearly 40% of the company, bringing its total shareholding to over 45%. Under takeover rules, Redmile must now make a cash offer for any remaining shares at the same price, of 15.5p ($0.20), valuing the company at around £29,45 million. UK biotech firm Redx Pharma (AIM: REDX) has a new majority shareholder, investment group Redmile, after the USA-based company bought up nearly 40% of the company, bringing its total shareholding to over 45%. Under takeover rules, Redmile must now make a cash offer for any remaining shares at the same price, of 15.5p ($0.20). Redx said that it would recommend unanimously to shareholders that the offer be accepted. hTTps://www.thepharmaletter.com/article/redx-pharma-set-to-be-bought-by-us-investment-group
13/3/2020
07:20
thefartingcommie: hTTps://www.sharesmagazine.co.uk/news/market/6828551/RECOMMENDED-MANDATORY-OFFER-FOR-REDX-PHARMA-PLC Under the Offer, which will be subject to the Acceptance Condition and further terms of which are set out in Appendix 1 of this Announcement and which will be set out in full in the Offer Document and Form of Acceptance, Redx Shareholders will receive: 15.5 pence in cash for each Redx Share held. · The Offer will extend to all issued Redx Shares which are not held by Redmile and any further Redx Shares which are unconditionally allotted or issued and fully paid before the Offer closes. · As a result of the Acquisition, Redmile will, in aggregate, hold 86,498,896 Redx Shares, representing approximately 45.5 per cent. of the existing issued share capital and voting rights of Redx. · The Offer Price represents a premium of approximately 210% per cent. to the Closing Price per Redx Share of 5 pence on 12 March 2020 (being the Last Practicable Date prior to the date of this Announcement).
Redx Pharma share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
REDX
Redx Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210123 01:50:10